Neurocrine Bio. (NBIX) PT Raised to $100 at BMO Capital
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $138.40 -0.39%
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $100.00 (from $96.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR3,620 at Citi
- Costco Wholesale (COST) PT Lowered to $1,010 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
